Related content

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

By Nakanishi Ryota   Harada Jun   Tuul Munkhbold   Zhao Yan   Ando Koji   Saeki Hiroshi   Oki Eiji   Ohga Takefumi   Kitao Hiroyuki   Kakeji Yoshihiro   Maehara Yoshihiko  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1042-1048

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 249-254

Spandidos Publications

Access to resources Recommend Favorite

Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer

By                  

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2519-2526

Spandidos Publications

Access to resources Recommend Favorite

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 163-171

Bentham Science Publishers

Access to resources Recommend Favorite

KRAS mutations and subtyping in colorectal cancer in Jordanian patients

By    

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 705-710

Spandidos Publications

Access to resources Recommend Favorite